These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17958347)

  • 21. De novo generation of molecular structures using optimization to select graphs on a given lattice.
    Bywater RP; Poulsen TA; Røgen P; Hjorth PG
    J Chem Inf Comput Sci; 2004; 44(3):856-61. PubMed ID: 15154750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.
    Durdagi S; Papadopoulos MG; Papahatjis DP; Mavromoustakos T
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6754-63. PubMed ID: 17980589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactive conformation analysis of cyclic imides as protoporphyrinogen oxidase inhibitor by combining DFT calculations, QSAR and molecular dynamic simulations.
    Zhang L; Hao GF; Tan Y; Xi Z; Huang MZ; Yang GF
    Bioorg Med Chem; 2009 Jul; 17(14):4935-42. PubMed ID: 19540767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
    Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
    Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
    Dolezal R; Van Damme S; Bultinck P; Waisser K
    Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ring system-based chemical graph generation for de novo molecular design.
    Miyao T; Kaneko H; Funatsu K
    J Comput Aided Mol Des; 2016 May; 30(5):425-46. PubMed ID: 27299746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach to predict aquatic toxicity from molecular structure.
    Castillo-Garit JA; Marrero-Ponce Y; Escobar J; Torrens F; Rotondo R
    Chemosphere; 2008 Sep; 73(3):415-27. PubMed ID: 18597811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR modeling of the interaction of flavonoids with GABA(A) receptor.
    Duchowicz PR; Vitale MG; Castro EA; Autino JC; Romanelli GP; Bennardi DO
    Eur J Med Chem; 2008 Aug; 43(8):1593-602. PubMed ID: 18158201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
    Hilpert K; Fjell CD; Cherkasov A
    Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
    San Juan AA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fingerprint-based clustering applied to define a QSAR model use radius.
    Sprous DG
    J Mol Graph Model; 2008 Sep; 27(2):225-32. PubMed ID: 18556228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.
    Viña D; Uriarte E; Orallo F; González-Díaz H
    Mol Pharm; 2009; 6(3):825-35. PubMed ID: 19281186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.
    Vicente E; Duchowicz PR; Castro EA; Monge A
    J Mol Graph Model; 2009 Aug; 28(1):28-36. PubMed ID: 19394254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding orientations, QSAR, and molecular design of thiophene derivative inhibitors.
    Liao SY; Chen TJ; Miao TF; Qian L; Zheng KC
    Chem Biol Drug Des; 2009 Sep; 74(3):289-96. PubMed ID: 19703031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.
    La Motta C; Sartini S; Tuccinardi T; Nerini E; Da Settimo F; Martinelli A
    J Med Chem; 2009 Feb; 52(4):964-75. PubMed ID: 19170633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantum-chemical foundations of the topological substructural molecular design.
    Estrada E
    J Phys Chem A; 2008 Jun; 112(23):5208-17. PubMed ID: 18491851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
    Vaidya M; Weigt M; Wiese M
    Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling the activity of furin inhibitors using artificial neural network.
    Worachartcheewan A; Nantasenamat C; Naenna T; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Eur J Med Chem; 2009 Apr; 44(4):1664-73. PubMed ID: 18977558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.